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Abstract
Background: Chondromodulin-I (ChM-I) is an anti-angiogenic glycoprotein that is specifically localized at the
extracellular matrix of the avascular mesenchyme including cartilage and cardiac valves. In this study, we
characterized the expression pattern of ChM-I during early pregnancy in mice in vivo and its effect on invasion of
trophoblastic cells into Matrigel in vitro.
Results: Northern blot analysis clearly indicated that ChM-I transcripts were expressed in the pregnant mouse
uterus at 6.5-9.5 days post coitum. In situ hybridization and immunohistochemistry revealed that ChM-I was
localized to the mature decidua surrounding the matrix metalloproteinase-9 (MMP-9)-expressing trophoblasts.
Consistent with this observation, the expression of ChM-I mRNA was induced in decidualizing endometrial stromal
cells in vitro, in response to estradiol and progesterone. Recombinant human ChM-I (rhChM-I) markedly inhibited
the invasion through Matrigel as well as the chemotactic migration of rat Rcho-1 trophoblast cells in a manner
independent of MMP activation.
Conclusions: This study demonstrates the inhibitory action of ChM-I on trophoblast migration and invasion,
implying the potential role of the ChM-I expression in decidual cells for the regulated tissue remodeling and
angiogenesis at feto-maternal interface.
Background
Chondromodulin-I (ChM-I) is a naturally occurring
anti-angiogenic glycoprotein that localizes to the avascu-
lar domains of mesenchymal tissues such as cartilage,
cardiac valves, and the eye [1-3], where angiogenesis is
strictly limited. Using both recombinant and adenovi-
rally expressed ChM-I protein, we have demonstrated
that ChM-I inhibits the migration, proliferation, and
tube morphogenesis of cultured vascular endothelial
cells, and suppresses tumor angiogenesis [4-8]. More-
over, ChM-I-deficient mice show a vascularized pheno-
type in their aged cardiac valves, which is caused by a
loss of anti-angiogenic valvular functions and abnormal
vascular invasion [2]. These studies suggest that ChM-I
may serve as a matrix component that confers anti-
angiogenic resistance to specific mesenchymal tissues.
During mouse skeletal development, expression of
ChM-I was dramatically increased in association with
cartilage formation. In situ hybridization revealed that
the transcripts were detected at the sites of chondrogen-
esis such as the occipital bone rudiments at 11 days p.c.
in mouse embryos. Then the specific expression of
ChM-I became apparent in all cartilaginous skeletal ele-
ments in the body including the nasal septum, tracheal
rings, ribs, and vertebral column [9]. Prior to chondro-
genesis, ChM-I transcripts were detected in cardiac
valve precursor cells of the heart at 9.5 days post coitum
(p.c.) and its expression persisted in cardiac valves in the
adult [2].
I nt h ec o u r s eo fo u rs t u d yt oe x p l o r et h es i t e so f
ChM-I expression in early stages of development, we
carried out northern blot analysis of pregnant mouse
uterus and found it to be a prominent expression site at
7.5 day p.c. or later. Then, after detailed analysis, we
unexpectedly found that intense (or strong) hybridiza-
tion signals were detected in maternal tissues such as
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nancy. In this study, we determined the differentiated
mouse decidua as a novel site of ChM-I expression and
found that ChM-I transcripts were induced by the
decidualization of endometrial stromal cells in vitro.W e
e x a m i n e dh e r eap o s s i b l ei n v o l v e m e n to fC h M - Ii n
angiogenic events and tissue remodeling of decidua by a
Matrigel invasion assay in vitro.
Results
Expression of ChM-I in the decidua during the early
implantation period
In mice, implantation occurs at between 4.5-5.0 days p.c.
and triggers the transformation of uterine stroma into
t h ec o h e s i v es p o n g yt i s s u ec a l l e dd e c i d u a .T h i se v e n t
accompanies drastic tissue remodeling via the uterine
angiogenesis and the invasion of trophoblasts to make
feto-maternal connections required for the maintenance
of pregnancy. By northern blot analysis, ChM-I tran-
scripts were undetectable in the uterus at 5.5 days p.c.
as well as in the non-pregnant mouse uterus (Figure
1A). These transcripts became barely detectable at 6.5
days p.c. and were at their most abundant levels at 7.5
days p.c. The expression levels gradually declined from
the onset of placentation (around 8.5 days p.c.) onward.
The temporal pattern of ChM-I expression was thus
found to be similar to that of Prl8a2 (prolactin family 8,
superfamily a, member 2) (Figure 1A), which is
expressed in the trophoblasts and the decidua [10]. In
contrast, transcripts for TIMP-3 (tissue inhibitor of
matrix metalloproteinase-3) and VEGF-A164 (vascular
endothelial growth factor-A164), both known angiogen-
esis-related gene products expressed in the decidua,
increased until 7.5 days p.c., and then rapidly disap-
p e a r e d .A ss h o w ni nF i g u r e1 B ,R T - P C Ra n a l y s i so fa
pregnant mouse uterus (7.5 days p.c.) indicated that
ChM-I expression was strongly detected in the maternal
decidua that also expressed Prl8a2, but was marginal in
the embryonic tissue that was positive for Brachyury,a
marker of the mesoderm [11]. The placenta (13.5 days
p.c.), which is formed through the fusion of the decidua,
EPC (ectoplacental cone), chorion, and parts of the
allantois, was also positive for ChM-I.
In situ hybridization revealed that the ChM-I tran-
scripts were first detected around the EPC, which con-
tains undifferentiated populations of trophoblast, at 6.5
days p.c. (Figure 2A). Interestingly we found that TIMP-3
was strongly expressed in the primary decidua, a mature
portion of this structure, and that the localization of
TIMP-3 transcripts was complementary to that of ChM-I
(Figure 2B). At 7.5 days p.c., the site of ChM-I expression
was considerably expanded to the entire primary decidua,
whilst TIMP-3 expression was restricted to the thin layer
of the primary decidua closer to the implanting embryo.
The expression sites of these angiogenesis inhibitors
were found to overlap with that of Prl8a2 (Figure 2I) and
the invasive trophoblast giant cells that express a high
level of MMP-9 (matrix metalloproteinase-9) and Prl3d1
(prolactin family 3, superfamily d, member 1) (Figures
2D-J) at the margin of the implantation chamber. By 8.5
days p.c., ChM-I transcripts were found to be expressed
at a lower level around the EPC, where MMP-9 expres-
sing trophoblast giant cells invade the decidua basalis to
form the placenta (data not shown). These dynamic
changes in the expression pattern of ChM-I are sugges-
tive of their functional role in regulating the invasion of
MMP-9 expressing trophoblasts.
Localization of ChM-I protein in the decidua
Just after implantation, trophoblasts immediately invade
the decidual matrix and form vascular connections with
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Figure 1 Expression of ChM-I in the mouse uterus during early
pregnancy. (A) Northern blot analysis of ChM-I mRNA in the
pregnant mouse uterus. Total RNA was extracted from pregnant
mouse uteri (myometrium + decidua + embryo) and non-pregnant
mouse uteri, separated on a denatured agarose gel, and transferred
to a nylon membrane. The blots were then hybridized with a radio-
labeled probe for ChM-I, Prl8a2, TIMP-3, and VEGF-A164, respectively.
The equivalent loading of RNA (15 μg/lane) in each lane was
verified by ethidium bromide staining. Arrowheads indicate the
positions of the 28S and 18S ribosomal RNAs. (B) Total RNA was
extracted from decidua (7.5 days p.c.), non-pregnant mouse uteri (8-
week-old), embryos (7.5 days p.c., including extraembryonic tissues),
and placenta (13.5 days p.c.). The decidual tissues were prepared by
the removal of embryos and extraembryonic tissues from whole
decidual capsules. One microgram of each total RNA preparation
was reverse-transcribed, and the expression of ChM-I and marker
genes (Prl8a2, a marker for trophoblasts and decidua; Brachyury,a
marker for embryonic tissue) was analyzed by RT-PCR (30 cycles).
GAPDH was used as an internal control. The data are representative
of three independent experiments.
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Figure 2 Localization of ChM-I transcripts in the decidua.E x p r e s s i o no fChM-I ( A ,D ,a n dG ) ,TIMP-3 (B and E), and MMP-9 ( C ,F ,a n dH )
transcripts analyzed by in situ hybridization using semi-serial sections of 6.5 (A-C) and 7.5 (D-F) days p.c. mouse decidual capsules. Expression of
Prl8a2 (I) and Prl3d1 (a marker for trophoblasts; J) transcripts were also examined at 7.5 days p.c. Boxed areas in panels D and F are magnified in
panels G and H, respectively. Note that, at 7.5 days p.c., ChM-I transcripts were broadly detectable in the primary decidua surrounding the
implanting embryo and in MMP-9-positive cells (arrowheads in panel C and F), whilst TIMP-3 transcripts (arrowheads in panel E) were marginally
detected at the mesometrial side. All images are representative of at least three independent experiments. epc, ectoplacental cone; em, embryo;
dec, decidua. Bars in panels A-F and I-J, 300 μm; bars in panels G-H, 100 μm.
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Page 3 of 14the maternal blood supply [12]. We therefore examined
the localization of ChM-I protein in the decidua at 7.5
days p.c., comparing it with the distribution of maternal
vascular networks and invading trophoblasts (Figure 3).
To visualize the invading fetal tissue and the maternal
vasculature, transgenic male mice ubiquitously expres-
sing EGFP were mated with wild-type female mice, and
the decidual sections were stained with anti-PECAM-1
antibody (Figures 3A and 3B). PECAM-1 immunoreac-
tivity was detected in the whole decidua and was rela-
tively strong in the primary decidua surrounding the
EGFP-positive fetal invading cells (Figure 3B). Consis-
tent with its mRNA localization (Figure 2), secreted
ChM-I protein was detected in a punctate distribution
in the primary decidua, where PECAM-1-positive mater-
nal blood vessels and the invading trophoblasts may
strongly interact with each other (Figures 3C and 3D).
Expression of genes associated with angiogenesis and
ECM remodeling in cultured decidual cells and EPCs
Tissue remodeling and angiogenesis are two hallmark
events that represent active tissue-tissue interactions at
the feto-maternal interfaced u r i n gi m p l a n t a t i o na n d
decidualization. Invading trophoblasts express MMPs to
facilitate matrix remodeling, and respond to a number
of growth factors produced by the decidua. Concur-
rently, the maternal vasculature is also stimulated and
directed to the implanted embryo by angiogenic factors
produced in the decidua [13-15]. RT-PCR indicated that
decidual cells expressed angiogenic growth factors such
as VEGF-A, FGF-2 (fibroblast growth factor-2), and
IGF-I (insulin-like growth factor-I), whilst EPCs were
positive for their cognate receptors (Figure 4). Moreover,
EPCs predominantly expressed MMP-9, a molecule
believed to be crucial for tissue remodeling. In contrast,
cultured decidual cells expressed all of TIMPs that were
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Figure 3 Localization of ChM-I protein in the decidua. (A and B)
Visualization of invading fetal tissue through the decidua. Female
mice were mated with homozygous EGFP transgenic male mice. At
7.5 days p.c., decidual capsules were dissected from the pregnant
mice, fixed, and cryo-sectioned. Semi-serial sections were stained
with HE (A) and anti-PECAM-1 antibodies (B, red), respectively. Fetal
tissue (green) invading through the maternal decidua was observed
under a fluorescence microscope. (C and D) Localization of ChM-I
protein and PECAM-1-positive cells. Cryo-sections of 7.5 days p.c.
tissues were double-immunostained with anti-ChM-I antibody
(green) and anti-PECAM-1 antibody (red), and counterstained with
DAPI (panel D). All images are representative of at least three
independent experiments. epc, ectoplacental cone; em, embryo; dec,
decidua. Bars in panels A-C, 200 μm; Bar in panel D, 50 μm.
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Figure 4 Expression profiles of angiogenesis- and matrix
remodeling-related genes in cultured EPCs and decidual cells.
EPCs and decidual cells were isolated from decidual capsules at 7.5
days p.c. Decidual cells (5 × 10
5 cells/well in 6-multiwell plates) and
EPCs (10 EPCs/well in 6-multiwell plates) were cultured in DMEM
containing 10% FBS for 2-5 days, respectively. Total RNA was
isolated, reverse-transcribed, and the indicated sets of genes
associated with angiogenesis (left panel) and tissue remodeling
(right panel) were analyzed by RT-PCR (25 cycles for VEGF-A, Flk-1,
Flt-1, MMP-3, MMP-9, MMP-14, TIMP-1, TIMP-2, TIMP-3; 30 cycles for
FGF-2, FGFR-1, IGF-I, IGF-IR, MMP-1). GAPDH (25 cycles) was used as
an internal control. The data are representative of three
independent experiments.
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Page 4 of 14examined (Figure 4). These results are compatible with
the notion that trophoblasts are capable of responding
to angiogenic and anti-angiogenic signal cues produced
by the decidua.
Induction of ChM-I expression by the decidualization of
endometrial stromal cells in vitro
Decidualized endometrial stromal cells swell up their
cell volume and produce basement membrane-like
ECMs such as type IV collagen, laminin, and fibronectin
instead of the interstitial matrices [16,17]. To investigate
the expression of ChM-I in decidual cells, the cells were
enzymatically isolated from the decidual capsules of
mice at 7.5 days p.c., and cultured for seven days in
vitro i nt h ep r e s e n c eo f1 0 %f e t a lb o v i n es e r u m( F B S ) .
As previously reported [18,19], the isolated cells were
predominantly large, flattened, polygonal, and some
were multi-nucleated (Figure 5A, arrowheads). The
expression of ChM-I transcripts was monitored along
with the detection of decidual cell-differentiation marker
genes by RT-PCR (Figure 5B). While abundant type I
collagen transcripts were detected only in undifferen-
tiated endometrial stromal cells, a high level of type IV
collagen was maintained in the cultured cells [17]. (Fig-
ure 5B). In contrast, the expression levels of Prl8a2
markedly declined (Figure 5B) during one week of cul-
ture, although no morphological changes of cells were
apparent. Expression of ChM-I was readily detectable in
the 7.5 days p.c. decidual capsules, but the capacity for
ChM-I expression was only barely maintained when
decidual cells were transferred into culture.
Kimura and coworkers have demonstrated previously
that mouse endometrial stromal cells undergo deciduali-
zation in vitro i nt h ep r e s e n c eo f1 7 b-estradiol (E2) and
progesterone (P4) [20]. We isolated endometrial stromal
cells from 4-week-old immature female mice using their
protocol [20], and cultured the cells with or without E2
a n dP 4 .W i t h o u tE 2( 0 . 1n M )a n dP 4( 1 0 0n M ) ,e n d o -
metrial stromal cells retained the spindle-shaped mor-
phology of fibroblasts throughout the culture period.
However, when cultured in the presence of E2 and P4,
these cells adopted rounded morphologies with enlarged
and/or multiple nuclei (Figure 6A, arrowheads), resem-
bling the decidual cells in culture shown in Figure 5A.
RT-PCR analysis of total RNA from cells indicated that
there was no apparent expression of ChM-I when the
cells were cultured without E2 and P4 (Figure 6B). In
contrast, ChM-I and Prl8a2 transcripts were induced by
the addition of E2 and P4 to these cultures, even though
the expression level was relatively low compared with
that of the decidua at 7.5 days p.c. (Figure 6B). In situ
hybridization to the cultured cells revealed that no
hybridization signals were present in spindle-shaped
endometrial stromal cells cultured without E2 and P4,
but that hypertrophic rounded cells with enlarged and/
or multiple nuclei formed in the presence of E2 and P4
exhibited positive signals for Prl8a2 mRNA as a result
of decidualization (Figure 6C). Positive immunoreactivity
to ChM-I protein was readily detected also in these
decidualized hypertrophic cells (Figure 6D, arrowheads),
but not without E2 and P4. These results indicate that
ChM-I is induced in association with the decidualization
of endometrial stromal cells.
Effects of rhChM-I on the migration of Rcho-1 trophoblast
cells
Taking advantage of rat Rcho-1 trophoblast cells, which
are capable of recapitulating trophoblast giant cell dif-
ferentiation in vitro [21], we examined whether recom-
binant human ChM-I (rhChM-I) affects the chemotactic
migration of trophoblasts. In the growth medium,
Rcho-1 trophoblast cells retained an undifferentiated
state with a low level of expression of genes such as
Prl3d1, a marker for trophoblast differentiation, and
MMP-9, a terminal differentiation associated marker
(day 0, Figure 7A). When the cells reached confluence,
the culture medium was replaced with differentiation
medium containing horse serum. Expression of these
marker genes evidently increased by day 7 (Figure 7A).
No ChM-I transcripts were detected in cells cultured in
either growth or differentiation medium (Figure 7A).
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Figure 5 Loss of ChM-I expression in cultured decidual cells. (A)
Decidual cells were enzymatically isolated from decidual capsules
(7.5 days p.c.) and seeded at 5 × 10
5 cells/well in a 6-multiwell
plate. The cells were then cultured for seven days in DMEM
containing 10% FBS. Arrowheads indicate cells that have multiple-
or enlarged nuclei, which are characteristic of the differentiated
decidual cells. Bars, 100 μm. (B) Total RNA was isolated from
decidual cell cultures at the indicated time points, endometrial
stromal cells cultured for three days, and decidual tissue at 7.5 days
p.c. One microgram of total RNA was reverse-transcribed, and the
expression of ChM-I, Prl8a2, Col4a1, and Col1a2 was analyzed by RT-
PCR (25 cycles for Prl8a2, Col4a1, Col1a2; 35 cycles for ChM-I). The
data are representative of three independent experiments.
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Figure 6 Induction of ChM-I expression during the decidualization of mouse endometrial stromal cells in vitro.M o u s ee n d o m e t r i a l
stromal cells were enzymatically isolated from the uteri of 4 week-old non-pregnant mice and cultured in medium containing 10% charcoal-
stripped FBS. The in vitro decidualization of endometrial stromal cells was induced by the addition of E2 (0.1 nM) and P4 (100 nM) to the culture
media. (A) Representative microphotographs of the endometrial stromal cells cultured for nine days in the presence (lower panel) or absence
(upper panel) of E2 + P4. Arrowheads indicate enlarged or multi-nucleated cells that are characteristic of decidual cells. Bars, 50 μm. (B)
Expression of ChM-I and Prl8a2 in decidualized cultures of endometrial stromal cells. Total RNA was extracted from the cells at the indicated time
points and from mouse decidua (7.5 days p.c.). One microgram of each total RNA preparation was reverse-transcribed and analyzed by RT-PCR
(35 cycles) for comparison. GAPDH was used as an internal control. (C, D) Expression of Prl8a2 gene in decidualized cells and immunostaining of
ChM-I protein. The endometrial stromal cells were cultured for six days with or without E2 + P4, fixed, and subjected to in situ hybridization for
Prl8a2 (C) and immunostaining with anti-ChM-I antibody (D). Note that intense signals for ChM-I protein (arrowheads) were observed in enlarged
cells that also expressed Prl8a2. Bars, 30 μm. All images are representative of three independent experiments.
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Page 6 of 14The effects of rhChM-I were then tested using modified
Boyden chambers. Subconfluent Rcho-1 trophoblast
cells cultured in growth medium were serum-starved
and seeded onto migration inserts that had been coated
with fibronectin, one of the abundant matrix compo-
nents in the decidua. Among the angiogenic growth fac-
tors expressed in the decidual cells (Figure 4), FGF-2
(data not shown) and IGF-I, but not VEGF-A, exhibited
a pronounced stimulatory effect on the chemotactic
migration of Rcho-1 trophoblast cells. IGF-I induced
the migration of these cells by approximately two-fold
over the non-stimulated basal levels (Figure 7B). In con-
trast, the addition of rhChM-I to the cultures clearly
inhibited the IGF-I-induced migration of the cells in a
dose-dependent manner. At a dose of 0.5 μg/ml or
higher, IGF-I-induced migration was completely abol-
ished (Figure 7B).
Anti-invasive effects of rhChM-I upon Rcho-1 trophoblast
cells
The invasive activity of Rcho-1 trophoblast cells was
examined (Figure 8). Gelatin zymography revealed that
Rcho-1 trophoblast cells pro d u c e dt h ea c t i v ef o r mo f
MMP-9 in association with their differentiation to tro-
phoblast giant cells when the cells are cultured in differ-
entiation medium containing 10% horse serum (Figure
8A, upper panel). Activated MMP-9 was secreted as the
predominant gelatinolytic activity, and MMP-2 and their
zymogens were undetectable. GM6001 (25 μM), an inhi-
bitor of broad spectrum MMP, partially reduced the
activation of pro-MMP-9, but the addition of rhChM-I
in culture produced no apparent effect on the formation
of activated MMP-9 (Figure 8A, lower panel). Despite
this, rhChM-I clearly inhibited the invasion of differen-
tiated Rcho-1 trophoblast cells into Matrigel in a dose-
dependent manner (Figure 8B). Rcho-1 trophoblast cells
took on well-spread motile morphologies with active
lamellipodia formation (Figure 8C, upper panel) and
actively invaded a Matrigel layer in Boyden chamber
(Figure 8B) under low serum conditions with 0.5% horse
serum, which allow differentiation of the cells [21]. In
the presence of rhChM-I, most cells took on quite dis-
tinctive static morphologies suggestive of their lower
motility (Figure 8C, lower panel).
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Figure 7 Effects of rhChM-I on the IGF-I-induced migration of Rcho-1 trophoblast cells. (A) Expression of Prl3d1, MMP-9, and ChM-I in Rcho-1
trophoblast cells. Rcho-1 trophoblast cells were seeded at 2 × 10
5 cells/well in 6-multiwell plates and cultured in growth medium (NCTC-135
medium containing 20% FBS) until reaching confluence (day 0; undifferentiated). The culture medium was then replaced with differentiation
medium (NCTC-135 medium containing 10% horse serum), and the cells were cultured for seven days (day 7, differentiated) to promote their
differentiation to trophoblast giant cells. EPCs were isolated at 7.5 days p.c. and cultured for two days in DMEM containing 10% FBS and 15 mM
HEPES. Total RNA was then isolated and reverse-transcribed, and the expression of Prl3d1 (28 cycles), MMP-9 (28 cycles), and ChM-I (35 cycles) was
analyzed by RT-PCR. GAPDH (28 cycles) was used as an internal control. The gel images are representative of three independent experiments. (B)
Boyden chamber migration assay of Rcho-1 trophoblast cells. Serum-starved Rcho-1 trophoblast cells (1 × 10
5 cells/200 μl) were preincubated with
or without rhChM-I for 20 min, and then seeded onto fibronectin-coated cell culture inserts in NCTC-135 medium containing 0.5% FBS.
Chemotactic migration of Rcho-1 cells was induced by the addition of IGF-I (100 ng/ml) to the lower chamber. Cells were then allowed to migrate
for 6 h in the presence of various concentrations of rhChM-I. Control cells were treated with 0.1% BSA/PBS and allowed to migrate in the absence
of IGF-I. The number of cells that had invaded the undersurface of the insert was counted in five representative high power fields (under × 200
magnification) per insert. The values shown are percentages of the number of migrated cells compared with the control cells (22 ± 2.3 cells/field)
and are the means ± SD of a triplicate assay. The data are representative of three independent experiments. The statistical significances were
determined by the Student’s t-tests as compared to IGF-I alone (*P < 0.05, one-tailed).
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Along with the invasion of trophoblasts into the mater-
nal endometrium, sequential decidual reactions occur
and lead to the formation of two distinct zones: the dif-
ferentiated zone proximal to an implanting embryo
termed the primary decidual zone, and the distal
peripheral zone consisting of immature mitotic decidual
cells, termed the secondary decidual zone [22,23]. In our
present study, we have demonstrated that ChM-I is
expressed in the primary decidual zone during early
pregnancy in mice. In contrast to Prl8a2,w h i c hi s
broadly expressed in decidual tissue and strongly
A
rhChM-I
(μg/ml)
G
M
6
0
0
1
1 0
pro-MMP-9
activated MMP-9
0.3
2469 1 3
Culture Days 
in Differentiation Medium
MMP-9
B
C
rhChM-I
BSA
I
n
v
a
s
i
o
n
 
(
%
 
o
f
 
c
o
n
t
r
o
l
)
BSA 0.15 0.5 1.5 GM6001
rhChM-I (μg/ml)
120
100
80
60
40
20
0
*
*
*
Figure 8 Effects of rhChM-I on the invasion of Rcho-1 trophoblast cells. (A) Effects of rhChM-I on the production and activation of MMP-9
in cultures of Rcho-1 trophoblast cells. Cells were grown to confluence, and the culture medium was then replaced with differentiation medium
(NCTC-135 medium containing 10% horse serum). At the indicated time points (at day 2, 4, 6, 9, and 13), the culture medium was changed to
medium containing 1% horse serum and conditioned for 24 h. The gelatinolytic activity in the conditioned medium was analyzed by gelatin
zymography (upper panel). rhChM-I or GM6001 (25 μM) was added to cultures of Rcho-1 trophoblast cells in differentiation medium on day 9,
and the cells were incubated another for 24 h in medium containing 1% horse serum. The gelatinolytic activity in the conditioned medium was
then analyzed by gelatin zymography (lower panel). The gel images are representative of three independent experiments. (B) Matrigel invasion
assay of Rcho-1 cells. Subconfluent Rcho-1 trophoblast cells were harvested and resuspended in NCTC-135 medium containing 0.5% horse
serum, and seeded onto cell culture inserts (5 × 10
4 cells/200 μl) coated with a layer of Matrigel. The cells were allowed to invade for 16 h in
the presence of 0.1% BSA/PBS (control), various concentrations of rhChM-I, or GM6001 (25 μM) in NCTC-135 medium containing 0.5% horse
serum. The number of cells that had invaded the undersurface of the insert was counted under × 200 magnification. The values shown are
percentages of the number of invading cells compared with the control cells (361 ± 20.7 cells/field) and are the means ± SD of a triplicate
assay. The data are representative of three independent experiments with similar results. The statistical significances were determined by the
Student’s t-tests as compared to the control (0.1%BSA/PBS) (*P < 0.05, one-tailed). (C) Representative microphotographs of Rcho-1 trophoblast
cells that had invaded the bottom surface of the insert in the presence of 0.1% BSA/PBS (upper panel, control) or 1.5 μg/ml rhChM-I (lower
panel). Bars, 100 μm.
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Page 8 of 14induced during decidualization [10], ChM-I transcripts
were localized to well-differentiated decidual cells in the
primary decidual zone and were not detectable in the
secondary decidual zone. Consistent with this, ChM-I
was induced in cultured endometrial stromal cells that
were undergoing decidualization in the presence of
estrogen and progesterone in vitro. Both ChM-I protein
and Prl8a2 mRNA were evident in the enlarged multi-
nucleated well-differentiated cells in primary cultures of
decidual cells [24].
The invasion of trophoblasts and maternal blood ves-
sels are coordinately regulated in the primary decidual
zone during early pregnancy. It has been known that the
primary decidual zone remains to be vascularized prior
to the invasion of trophoblasts [23]. Interestingly, ChM-I
expression is predominantly detected at the mesometrial
side of primary decidua facing the zone of vasculariza-
tion, whereas the intense signals for TIMP-3 expression,
another marker for well-differentiated decidual cells
[25], were found at the antimesometrial side of primary
decidua. When the trophoblasts were extensively
detected along the margin of the implantation chamber
at 7.5 days p.c., ChM-I was expressed at the entire zone
of the primary decidua surrounding the invading tro-
phoblasts, suggesting that ChM-I may participate in the
invasion processes of trophoblasts.
The capacity for ECM degradation is one of the criti-
cal components required for the invasive behavior of
cells [26,27]. Trophoblasts indeed express various
kinds of proteinases, and proteinase inhibitors are loca-
lized in the decidua. For instance, it has been shown
that TIMPs, cystatins, and plasminogen activator inhi-
bitors are expressed in the distinct domains of the
decidua [25,28,29]. In particular, MMP-9 and TIMP-3
are expressed at considerably high levels in the periph-
ery of the implantation chamber and are thought to be
pivotal regulators of ECM remodeling during the inva-
sion of trophoblasts. However, trophoblast invasion
proceeded relatively unhindered by the administration
of a synthetic MMP inhibitor GM6001 into pregnant
mice or the overexpression of TIMP-1 [14], while
these treatments had led to a reduced size of the
decidua and mesometrial displacement of an embryo.
These observations are compatible with our present
results showing that GM6001 had only a marginal
inhibitory effect on the invasion of Rcho-1 trophoblast
cells. TIMP-3 had also little impact on the Matrigel
invasion of Rcho-1 trophoblast cells (data not shown).
In contrast, ChM-I exhibited remarkable anti-invasive
activity in the Matrigel invasion assay of Rcho-1 tro-
phoblast cells, even though it did not interfere with
the production and activation of gelatinases in the
cells. The anti-invasive activity of rhChM-I was also
evident in the Matrigel invasion of HUVECs [8], in
which GM6001 was ineffective to block the invasion of
cells (data not shown).
We have previously demonstrated that ChM-I inhi-
bits the migration of vascular endothelial cells induced
by angiogenic growth factors including VEGF-A, FGF-
2, and IGF-I [8]. As suggested by the present RT-PCR
study, EPCs are also capable of responding to these
growth factors. Indeed, it has been reported also that
IGF-I is a potent stimulator of mouse EPC cells and
human trophoblast migration [13,30,31]. Similarly,
IGF-I and FGF-2, but not VEGF-A (data not shown),
stimulated the migration of Rcho-1 trophoblast cells in
culture. Using a modified Boyden chamber assay, we
found that rhChM-I completely abolishes the IGF-I-
induced migration of Rcho-1 trophoblast cells.
Morphologies of ChM-I-treated Rcho-1 trophoblast
cells are also indicative of a critical reduction in cellu-
lar motility. This mode of ChM-I action is analogous
to that on HUVECs [8]. Thus, ChM-I is likely to inhi-
bit the invasion of Rcho-1 trophoblast cells and vascu-
lar endothelial cells by suppressing their cellular
motility stimulated by IGF-I.
Conclusions
The present study demonstrates that ChM-I is expressed
in the primary decidual zone during decidualization at
feto-maternal interface. Recombinant ChM-I inhibited
the migration and invasion of Rcho-1 trophoblast cells
in a manner independent of MMP activation in vitro.
Methods
Antibodies and reagents
A purified rat anti-mouse CD31 (PECAM-1) monoclo-
nal antibody was purchased from BD Pharmingen (San
Diego, CA). A rabbit anti-ChM-I polyclonal antibody
was raised against recombinant human ChM-I expressed
in CHO cells [32]. Alexa Fluor 594-conjugated goat
anti-rat IgG and Alexa Fluor 488-conjugated goat anti-
rabbit IgG antibodies were obtained from Molecular
Probes (Eugene, OR). E2 and P4 were purchased from
Sigma (St. Louis, MO). GM6001 (a broad-spectrum
MMP inhibitor) was obtained from Merck KGaA
(Darmstadt, Germany). Growth factor reduced BD
Matrigel Matrix and mouse recombinant IGF-I was pur-
chased from BD Biosciences (Bedford, MA) and R&D
Systems (Minneapolis, MN), respectively.
Expression and purification of recombinant human ChM-I
Recombinant human ChM-I (rhChM-I; corresponding
to the region Glu
215-Val
334 of the human ChM-I precur-
sor) was expressed in a secreted form of an N-terminally
FLAG-tagged fusion protein using the pCAGGS expres-
sion vector (generously donated by Dr. J. Miyazaki,
Osaka University Graduate School of Medicine, Japan)
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Page 9 of 14[33]. The expression of rhChM-I under serum-free con-
ditions and its purification from the culture supernatant
were performed using the FreeStyle 293 Expression sys-
tem (Invitrogen, Carlsbad, CA) and anti-FLAG M2 affi-
nity gel (Sigma) according to the manufacturer’s
instructions [8].
Tissue dissections
Pregnant and non-pregnant C57 BL/6 female mice were
purchased from SHIMIZU Laboratory Supplies (Kyoto,
Japan). All experimental procedures involving the use of
animals for experimental purposes were approved by the
Animal Care Committee of the Institute for Frontier
Medical Sciences (Kyoto University) in accordance with
institutional guidelines under the protocol number E-
24-3. Mice were housed in a temperature and humidity
controlled facility in Laboratory of Animal Experiments
for Regeneration (Institute for Frontier Medical
Sciences, Kyoto University) with a 12 h light/dark cycle
and allowed access to food and water ad libitum.
Female mice were checked for pregnancy by the pre-
sence of vaginal plugs in the morning (midnight = 0 day
p.c.) and sacrificed by cervical dislocation. Uteri were
removed from pregnant mice, cut open, and decidual
capsules were then teased out. Using thin-needled for-
ceps, embryos were removed from the decidua, and
EPCs (ectoplacental cones; detectable as a cone-shaped
vascularized region) were carefully separated from the
distal endoderm at 7.5 days p.c. The placenta was sepa-
rated from the C57 BL/6 pregnant mice (13.5 days p.c.).
Some decidual samples or EPCs were prepared from the
EGFP-transgenic female mice [34] (kindly provided by
Dr. Masaru Okabe, Research Institute for Microbial Dis-
eases, Osaka University, Japan) mated with wild-type
C57 BL/6 male mice to track invading trophoblast cells
as reported by Rosario et al [35].
Cell culture
Isolation of decidual cells was carried out as described
previously [36] with minor modifications. Briefly,
decidual capsules were removed from ICR pregnant
mice at 7.5 days p.c. and minced into small pieces in
Hank’s balanced salt solution-calcium/magnesium free.
The minced tissues were then incubated at 37°C for 5
min in 0.05% type IV collagenase (Sigma) containing
0.02% deoxyribonuclease I (DNase I, Sigma), followed
by incubation in 0.007% collagenase with 0.02% DNase
I and 0.008% type XIV proteinase (Sigma) at 37°C for
5 min. The tissues were then triturated, and the super-
natant was centrifuged at 1000 rpm for 5 min. Cell
pellets were suspended in Dulbecco’s modified Eagle
medium (DMEM; Sigma) containing 10% FBS, and the
cells were seeded at 5 × 10
5 cells/well in 6-multiwell
plates.
Mouse endometrial stromal cells were isolated and
cultured as previously described with minor modifica-
tions [20]. Briefly, uteri were removed from immature 4-
week-old ICR mice, slit longitudinally to expose the
endometrial surface, and minced into small pieces in
PBS. The minced tissues were then incubated in 0.25%
type IV collagenase (Sigma) and 0.3% bovine serum
albumin (BSA; Sigma) in PBS for 1 h at 37°C. After
enzymatic digestion, the supernatant was passed through
a 40-μm cell strainer (BD Biosciences), centrifuged at
1000 rpm for 5 min, and the pelleted cells were rinsed
with phenol red-free DMEM. The cells were then resus-
pended in DMEM supplemented with 10% charcoal-
stripped FBS, 100 U/ml penicillin and 100 μg/ml strep-
tomycin, seeded at 7.5 × 10
5 cells/well in 6-multiwell
plates, and incubated in a humidified atmosphere of 5%
CO2 in air for 1 h. After the 1 h incubation, unattached
cells were gently removed with medium. For the in vitro
decidualization, endometrial stromal cells were cultured
with or without E2 and P4 at a concentration of 0.1 nM
and 100 nM, respectively. The culture medium was
changed every other day.
Rcho-1 trophoblast cells were obtained from Dr. M. J.
Soares (University of Kansas Medical Center, Kansas
City, USA) [21,37]. The cells were maintained in
NCTC-135 medium (Sigma) supplemented with 10 mM
HEPES, 50 μM b-mercaptoethanol (Sigma), 1 mM
sodium pyruvate (Sigma), 50 μg/ml kanamycin sulfate
(Sigma), and 20% FBS (growth medium). For the induc-
tion of differentiation, Rcho-1 cells in confluent culture
were maintained in NCTC-135 medium containing 10%
horse serum (GIBCO; differentiation medium). The cul-
ture medium was changed every other day. EPCs dis-
sected from decidua at 7.5 days p.c. were cultured in
DMEM supplemented with 10% FBS and 15 mM
HEPES at 37°C under 5% CO2 in air.
RNA preparation and RT-PCR
Total RNA extracts were prepared from tissues and cells
using the single step method of Chomczynski and Sac-
chi [38]. First strand cDNA was synthesized from 1 μg
of total RNA using SuperScript II RNase H- reverse
t r a n s c r i p t a s e( G i b c oB R L ,G r a n dI s l a n d ,N Y ) .T h e
amplification of glyceraldehyde-3-phosphate-dehydro-
genase (GAPDH) gene was utilized as an internal con-
trol. The primers used for RT-PCR are listed in Table 1.
cDNA fragments for hybridization
A 739 bp fragment of mouse ChM-I (GenBank acces-
sion no. NM_010701) cDNA was amplified from cDNAs
prepared from differentiated ATDC5 cells by RT-PCR
and subcloned into pCRII TOPO TA cloning vector
(Invitrogen). A 515 bp fragment of the mouse TIMP-3
(tissue inhibitor of metalloproteinase-3; GenBank
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ment of mouse MMP-9 (matrix metalloproteinase-9;
GenBank accession no. NM_013599) were amplified
from Mouse 17-day Embryo Marathon-Ready cDNA
(Clontech, Palo Alto, CA). Both of the amplified cDNA
fragments were then subcloned into the pCRII TOPO
vector. Similarly, a 628 bp cDNA fragment of mouse
Prl8a2 (prolactin family 8, superfamily a, member 2, also
known as decidual/trophoblast prolactin-related protein;
Gene accession number: NM_010088) was amplified
using cDNA from 7.5 days p.c. decidua, and subcloned.
A 551 bp cDNA fragment of mouse Prl3d1 (prolactin
family 3, superfamily d, member 1, also known as pla-
cental lactogen-I; Gene accession number: NM_008864)
was also amplified using cDNAs prepared from 7.5 days
p.c. EPCs, and subcloned. The partial 624 bp cDNA
fragment of mouse VEGF-A164 (Gene accession number:
NM_001025250) was amplified from Mouse 11-day
Embryo Marathon-Ready cDNA by RT-PCR and sub-
cloned into pBluescriptII SK (+) at the NotI site. The
primers used are listed in Table 2.
Northern blot analysis
Total RNA (15 μg) was denatured with 6.5% formalde-
hyde, resolved on a 1% formaldehyde-agarose gel,
transferred onto a nytran membrane (Schleicher &
Schuell, Dassel, Germany), and cross-linked by UV
irradiation. The cDNA fragments for hybridization
probes were labeled with [a-
32P] dCTP (Amersham
Biosciences, Piscataway, NJ) by the random-primer
method using a BcaBEST labeling kit (Takara, Shiga,
Japan). Hybridization was carried out as described pre-
viously [39].
In situ hybridization
Tissues samples were fixed with 4% paraformaldehyde
(PFA)/PBS for 16 h at 4°C, embedded in paraffin, and
c u ta tat h i c k n e s so f6μm. The sections were dewaxed,
rehydrated, treated with 10 μg/ml Proteinase K (Invitro-
gen) for 10-30 min at 25°C. For the cultured endome-
trial stromal cells, the cells were briefly fixed with 4%
PFA/PBS at room temperature. Antisense and sense
riboprobes for each gene were prepared with appropri-
ate cDNA fragments, and labeled using a digoxygenin
(DIG) RNA labeling kit (Roche, Mannheim, Germany).
Hybridization was carried out at 50°C for 16 h in hybri-
dization buffer containing 600 mM NaCl, 10% dextran
sulfate, 1 × Denhardt’s solution, 50% deionized forma-
mide, 200 mg/ml tRNA, 10 mM Tris-HCl (pH7.5), and
1 mM EDTA. Sections were then rinsed under high
stringency. Hybridization signals were detected immu-
nohistochemically using an alkaline-phosphate-conju-
gated antibody, according to the manufacturer’s
instructions (Roche Diagnostics).
Table 1 Primers for RT-PCR analysis
Genbank acc no. Gene 5’-Forward primer-3’ 5’-Reverse primer-3’ Size (bp)
NM_010701 ChM-I CATCGGGGCCTTCTACTTCT CTGCGTCGTCCTGAACATTGGG 584
NM_010088 Prl8a2 TGAATGTCAAACAGGAGAGAA CAATCTTGCCCAGTTATGCGG 628
NM_008864 Prl3d1 GCTTCCATCCATACTCCAG TCGTTCTGAAAGACAACTCG 419
NM_009309 Brachyury CTGCAGTCCCATGATAACTGGTCTAGC CCAGGATTTCAAAGTCACATATATGTTGTAG 717
NM_009931 Col4a1 TGTCCAAGGCAACGAGCGTG TGTTCTTCTCATGCACACTTGG 583
NM_007742 Col1a2 GAACGGTCCACGATTGCATG GGCATGTTGCTAGGCACGAAG 401
NM_001025250 VEGF-A CAGAGAGCAACATCACCATGC TCCTCGAAGGATCTCCTCTTCC 313, 445
NM_010612 Flk-1 CACAGACACCACCGTGTACTCC CTCCAAGGTAGACAGACTCGGC 516
NM_010228 Flt-1 TATGGTCTGTGTGCTTAGGTCG ACAGGACCATCTATGGTCTTCC 476
NM_008006 FGF-2 AGCGGCATCACCTCGCTTCC TGGAAGCAGTATGGCCTTCTGTCC 433
NM_010206 FGFR-1 AGAGACCAGCTGTGATGA GGCCACTTTGGTCACACG 461
NM_010512 IGF-I GGACCAGAGACCCTTTGCGGGG GGCTGCTTTTGTAGGCTTCAGTGG 210
NM_010513 IGF-IR ATGCTGTTTGAACTGCAGCGCATGTGCTGG CCGCTCGAGCTTGCGGCCCCCGTTCAT 354
NM_010809 MMP-3 GAAATGCAGAAGTTCCTCGG GAGTTCCATAGAGGGACTGA 878
NM_013599 MMP-9 TGTCATCCAGTTTGGTGTCG TAGGGCAGAAGCCATACAGT 433
NM_008607 MMP-13 TGAAGAGACTGAGCGCTGCG ATTCTTCCATGTGGTTCCAGCC 461
NM_008608 MMP-14 ATCATTGAGGTGGATGAGGAGG CAGCCAACCAGGTACACTTGG 614
NM_001044384 TIMP-1 AGTAAGGCCTGTAGCTGTGCC ACGAGGACCTGATCCGTCC 467
NM_011594 TIMP-2 AGCAGTGAGCGAGAAGGAGG TCACTTCTCTCGATGCAGGC 450
NM_011595 TIMP-3 GCTACTGCAGCTGGTACCG TTGGACTTCTGCCAACTTCC 518
NM008084 GAPDH ACCACAGTCCATGCCATCAC TCCACCACCCTGTTGCTGTA 452
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Tissue samples were passed through a series of sucrose/
PBS solutions (12%, 15%, and 18%), frozen in O.C.T.
compound (Sakura Finetek & Tissue-Tek, Tokyo,
Japan), and cryo-sectioned at a thickness of 8 μm. The
frozen sections were then fixed with 4% PFA/PBS for 10
min at room temperature, rinsed with TBST (Tris-buf-
fered saline containing 1% Tween 20), and incubated at
4°C overnight with primary antibody. For immunofluor-
escent staining, the sections were incubated with Alexa
Fluor 488-conjugated goat anti-mouse IgG secondary
antibody (1:300 dilution) or Alexa Fluor 594-conjugated
goat anti-rat IgG secondary antibody (1:300 dilution),
and 1 μg/ml of 4’, 6-diamidino-2-phenylindole (DAPI,
Sigma) in 2% skim milk/PBS. The slides were then
washed with TBST and observed under a fluorescent
microscope.
Matrigel invasion assay
Both the upper and under surfaces of cell culture
inserts (8 μm-sized pore filter; BD Biosciences) were
coated with fibronectin (5 μg/ml; BD Biosciences) for 4
ha tr o o mt e m p e r a t u r e .A na m o u n to f1 0 0μlo f0 . 5
mg/ml growth factor-reduced Matrigel (BD Biosciences)
in PBS was then added to the upper compartment of
the insert, followed by an incubation for 6 h at room
temperature to solidify the gel. When grown to subcon-
fluence, Rcho-1 trophoblast cells were harvested with
trypsin/EDTA, and re-suspended in NCTC-135 medium
containing 0.5% horse serum at 2.5 × 10
5 cells/ml. The
cells (5 × 10
4 cells/200 μl) were seeded onto the Matri-
gel-coated cell culture insert and incubated at 37°C in
5% CO2 for 16-18 h. The test reagent (rhChM-I or
GM6001) was added to both the upper (200 μl) and
lower chamber (600 μl). After incubation for 16 h, the
cells were fixed for 15 min with 0.25% glutaraldehyde,
and stained with Giemsa staining solution. Non-invad-
ing cells remaining on the upper surface of the insert
were wiped off, and the number of cells that had
invaded the undersurface of the insert was counted for
five representative high power fields (under × 200 mag-
nification) per insert.
Cell migration assay
The migration of Rcho-1 trophoblast cells was evaluated
using a modified Boyden chamber assay. The upper and
under surfaces of the cell culture inserts (5 μm-sized
pore filter, BD Biosciences) were coated with fibronectin
(5 μg/ml) at 4°C overnight. Subconfluent Rcho-1 tro-
phoblast cells were harvested and resuspended in
NCTC-135 medium containing 0.5% FBS (1 × 10
5 cells/
200 μl). The cells were then preincubated with or with-
out rhChM-I for 20 min and seeded onto the upper sur-
face of the inserts. Chemotactic migration of the cells
was induced by the addition of IGF-I (100 ng/ml) in the
lower chamber (600 μl). The cells were then allowed to
migrate for 6 h at 37°C in the presence or absence of
rhChM-I. The number of cells that had migrated to the
undersurface of the insert was counted in five represen-
tative fields at a higher magnification (× 200 magnifica-
tion) per insert.
Gelatin zymography
Gelatinolytic activity in the conditioned medium of
Rcho-1 trophoblast cell cultures was assessed by gelatin
zymography. Rcho-1 trophoblast cells were seeded at 2
×1 0
5 cells/well in 6-multiwell plates and grown to con-
fluence in growth medium. The culture medium was
then replaced with differentiation medium and the cells
were maintained for a further 13 days. The cells were
then conditioned at the indicated time points for 24 h
in NCTC-135 medium containing 1% horse serum with
or without test reagent. The conditioned media were
centrifuged, and the supernatants were mixed with the
same volume of × 2 non-reducing SDS sample buffer
[125 mM Tris-HCl (pH6.8), 20% glycerol, and 4% SDS].
The samples were next separated on a 7.5% SDS-polya-
crylamide gel containing 2 mg/ml gelatin (Sigma). After
electrophoresis, the gel was rinsed twice in 2.5% Triton
X-100 to remove the SDS, then incubated in 50 mM
Tris-HCl (pH8.0) buffer containing 5 mM CaCl2 to
allow gelatinolysis for 16-20 h. Gels were stained with
Coomassie Brilliant Blue R-250. The clearing of back-
ground gelatin by proteinases revealed gelatinolysis as
clear bands.
Table 2 Primers for cDNA fragment cloning
Genbank acc no. Gene 5’-Forward primer-3’ 5’-Reverse primer-3’ Size
(bp)
NM_010701 ChM-I GGGTCAATGGAAATAGATGCT ACACCATGCCCAGGATGCGG 739
NM_011595 TIMP-3 GCTACTGCAGCTGGTACCG TTGGACTTCTGCCAACTTCC 515
NM_013599 MMP-9 GATGCTATTGCTGAGATCCAGG GGAAGATGTCGTGTGAGTTCC 433
NM_008864 Prl3d1 GACCTGTATACTCGTTTGGC TCGTTCTGAAAGACAACTCG 551
NM_010088 Prl8a2 TGAATGTCAAACAGGAGAGAA CAATCTTGCCCAGTTATGCGG 628
NM_001025250 VEGF-A *GAAACCATGAACTTTCTGCTCTC *GGTGAGAGGTCTGGTTCCCG 624
* The following sequence was added at the 5’-end of the primer. Added sequence: ATAAGAATGCGGCCGC
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